Faculty News
Professor Aswath Damodaran's research on pharmaceutical companies is cited
—
![Wall Street Journal logo Wall Street Journal logo](/sites/default/files/styles/480w/public/assets/images/wsjlogo.jpg?itok=RJJEjM0o)
Excerpt from The Wall Street Journal -- "The other great problem is the ability of pharmaceutical and biotechnology companies to charge whatever the market will bear. According to a January 2015 analysis by Aswath Damodaran, a professor at New York University’s Stern School of Business, the average yearly profit margin for the top 151 pharmaceutical companies world-wide is more than 24% and for the top 400 biotech firms it is nearly 23%."
Read more
Read more